EFTA00304870.pdf

Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Clientheonnation EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR047985L Requisition: 0006030 Collected: Received: Reported: 08/14/2018 08/15/2018 15:11 EDT 08/16/2018 14:56 EDT Test Name LIPID PANEL, STANDARD CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL In Range Out Of Range 233 H 29 L 541 H LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 8.0 H NON HDL CHOLESTEROL 204 H For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40 mg/dL <150 mg/dL mg/dL (calc) <5.0 (calc) <130 mg/dL (calc) mg/L HONOCYSTEINE 20.5 H <11.4 Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. Lab MI MI MI MI MI MI TP umol/L MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE I OF5 EFTA00304870 rajQuest Diagnostics' -00 Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR047985L Collected: 08/14/2018 Received: 08/15/2018 / 15:11 EDT Reported: 08/16/2018 / 14:56 EDT Client #: 78300020 MOSKOWITZ. BRUCE W Test Name COMPREHENSIVE METABOLIC PANEL GLUCOSE In Range 95 Out Of Range Reference Range UREA NITROGEN (BUN) 21 CREATININE 1.16 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT HEMOGLOBIN Ale For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. 65-99 mg/dL Fasting reference interval 7-25 mg/dL 0.70-1.25 mg/dL Lab MI 66 76 NOT 139 4.4 105 23 APPLICABLE > OR = 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (calc) 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 20-32 mmol/L 9.8 8.6-10.3 mg/dL 7.0 6.1-8.1 g/dL 4.2 3.6-5.1 g/dL 2.8 1.9-3.7 g/dL (calc) 1.5 1.0-2.5 (calc) 0.8 0.2-1.2 mg/dL 55 40-115 U/L 23 10-35 U/L 35 9-46 U/L 5.7 H <5.7 % of total Hgb MI For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID Therapeutic target TSH T4 (THYROXINE), TOTAL FREE T4 INDEX (T7) T3 UPTAKE SED RATE BY MODIFIED for gout patients: 8.3 H <6.0 mg/dL 4.0-8.0 mg/dL MI 2.31 0.40-4.50 mIU/L MI 7.9 4.9-10.5 mcg/dL MI 2.4 1.4-3.8 30 22-35 % MI MI CLIENTSERIIICES:866.6971378 SPECIMEN: MR047985L Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 5 EFTA00304871 rajQuest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: Collected: Received: Reported: MR047985L 08/14/2018 08/15/2018 / 15:11 EDT 08/16/2018 / 14:56 EDT Client #: 78300020 MOSKOWITZ, BRUCE W Test Name WESTERGREN CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT RED BLOOD CELL COUNT HEMOGLOBIN HEMATOCRIT MCV MCH MCHC RDW PLATELET COUNT MPV ABSOLUTE NEUTROPHILS ABSOLUTE LYMPHOCYTES ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE See Endnote 2 VITAMIN B12 In Range 9 Out Of Range Reference Range < OR = 20 mm/h 5.9 3.8-10.8 Thousand/uL 5.12 4.20-5.80 Million/uL 15.1 13.2-17.1 g/dL 44.5 38.5-50.0 % 86.9 80.0-100.0 fL 29.5 27.0-33.0 pg 33.9 32.0-36.0 g/dL 13.8 11.0-15.0 % 248 140-400 Thousand/uL 9.7 7.5-12.5 fL 2879 1500-7800 cells/uL 2018 850-3900 cells/uL 502 200-950 cells/uL 443 15-500 cells/uL 59 0-200 cells/uL 48.8 34.2 8.5 7.5 1.0 373 200-1100 pg/mL Please Note: Although the reference range for vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1% of patients with values above 400 pg/mL will have symptoms. C-REACTIVE PROTEIN MERCURY, BLOOD 1.6 <8.0 mg/L <5 <OR=10 mcg/L This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. EXTRA BLUE-TOP TUBE AN EXTRA SPECIMEN WAS RECEIVED WITH NO TEST REQUESTED. THE SPECIMEN WILL BE MAINTAINED IN STORAGE IN CASE ADDITIONAL TESTING IS NEEDED. PLEASE CALL THE CLIENT SERVICE DEPARTMENT FOR FURTHER ASSISTANCE. PROLACTIN 3.9 TESTOSTERONE, TOTAL MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 150 L In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a 2.0-18.0 ng/mL 250-827 ng/dL Lab MI MI MI MI AT MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F5 EFTA00304872 rajQuest Diagnostics' —00 Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR047985L Collected: 08/14/2018 Received: 08/15/2018 / 15:11 EDT Reported: 08/16/2018 / 14:56 EDT Client #: 78300020 M0SK0WITZ. BRUCE W Test Name red-top tube with no gel. Endnote I In Range * Test not performed. * No specimen received. * * Out Of Range Reference Range Lab CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304873 Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY Specimen: MR047985L Client #: 78300020 Collected: 08/14/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/15/2018 I 15:11 EDT Gender: M Reported: 08/16/2018 I 14:56 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab VITAMIN D,25-OH,TOTAL,IA Vitamin D Status 32 30-100 ng/mL MI Deficiency: Insufficiency: Optimal: For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: http://education.questdiagnostics.com/faq/FAQ163 (This link is being provided for informational/ educational purposes only.) 25-OH Vitamin D: <20 ng/mL 20 - 29 ng/mL > or = 30 ng/mL Physician Comments: PERFORMING SITE: AT QUEST DIAGNOSTICS.ATLANTA. 1777 MONTMEAL CIRCLE.11JCICER. GA 30084-6S02 Laboratocy Duccior ANDREW N YOUNG.MD.PIID.CLIA: I I D0255931 MI QUIST DIAGNOSTICS-MIAML 1 two COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Laboratory DIrector GLEN L NORM MD PHD. CL1A: 10110277312 TP QUEST DIAGNOSTICS-TAMPA. 4225 E FOWLER AVE TAMPA. FL 33617.2026 Laboratory Duector GLEN L CL1A: 10110291120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304874